COMPANY OVERVIEW

Impact Biomedicines, Inc. (Impact) is pioneering the development of life-changing treatments for patients with myeloproliferative neoplasms and other cancers

---

LOCATION

San Diego, CA, USA

---

THERAPEUTIC AREAS

---

WEBSITE

https://impactbiomedicines.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jan 7, 2018

Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies

Dec 11, 2017

Impact Biomedicines Presents Analysis at the 2017 ASH Annual Meeting Suggesting that Fedratinib Did Not Increase Wernicke Encephalopathy Risk in Phase 2 and 3 Myelofibrosis Clinical Trials

Dec 1, 2017

Impact Biomedicines Closes First Tranche of Oberland Capital Financing Following FDA Meeting

Oct 26, 2017

Impact Biomedicines Closes $90 Million Financing with Oberland Capital to Fund Fedratinib Program Advancement

Oct 13, 2017

Startup Impact Biomedicines Raises $22M to Bring Fedratinib to Myelofibrosis Patients

For More Press Releases

---